secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRISPR Therapeutics AG (CRSP)
CIK:        0001674416
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0000950170-23-010439
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRISPR Therapeutics board member Brad Bolzon resigns after nearly a decade
--------------------------------------------------------------------------

- Brad Bolzon, Chairman and Managing Director of Versant Ventures, resigned from CRISPR Therapeutics board effective March 28, 2023.
- Resignation was not due to any dispute or disagreement with the company or its board.
- Bolzon served nearly a decade and was instrumental in defining the company's vision and strategy since its founding.
- No replacement named; company expressed gratitude for his contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674416/000095017023010439/0000950170-23-010439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674416/000095017023010439/crsp-20230328.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-010439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer